Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 7 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
IMMO MEDIMOL from Mol, company number BE0823052819, closed financial year 2025 with a result of € 76,911 after tax. For that financial year IMMO MEDIMOL recorded a gross margin of € 187,611 and equity of € 591,717. Compared with financial year 2024, the result moved from € 66,936 to € 76,911. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 591,717
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 76,911
▲ 15% vs 2024
Profit after tax over the fiscal year.
€ 36,705
▲ 244% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 54,882 paid out
71 % of the profit went to the shareholders, the rest stayed in the company.
Debts at end 2025
€ 460,152
▼ 15% vs 2024
€ 5,310 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 4,436
▲ € 3,469 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,229
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 161,191 | € 174,012 | € 185,311 | € 187,611 | ▲ 1% |
| Profit after taxes | € 66,787 | € 60,926 | € 66,936 | € 76,911 | ▲ 15% |
| Equity | € 543,744 | € 550,279 | € 569,688 | € 591,717 | ▲ 4% |
| Total debts | € 759,561 | € 692,435 | € 623,905 | € 575,954 | ▼ 8% |
| Cash | € 22,009 | € 8,300 | € 10,660 | € 36,705 | ▲ 244% |
| Land & buildings | € 1,278,138 | € 1,226,371 | € 1,182,365 | € 1,129,812 | ▼ 4% |
| Retained profit | € 343,744 | € 350,279 | € 369,688 | € 391,717 | ▲ 6% |
| Dividend | € 0 | € 54,391 | € 47,528 | € 54,882 | ▲ 15% |
| Bank debt | € 712,061 | € 628,091 | € 544,121 | € 460,152 | ▼ 15% |
| Balance sheet total | € 1,303,305 | € 1,242,715 | € 1,193,593 | € 1,167,670 | ▼ 2% |
Key figures of IMMO MEDIMOL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to IMMO MEDIMOL?
What happened at IMMO MEDIMOL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 76,911 (▲ 15% vs 2024). Source: NBB ↗
- New establishment in Mol. KBO
- Start of the company according to the CBE. KBO
In short
From € 66,787 profit in 2022 to € 76,911 profit in 2025.
Paid € 126,648 in corporate taxes since 2022.
Best year ever: 2025, with € 76,911 profit.
Paid out € 156,800 in dividends to the owners in total.
A new publication or filing at IMMO MEDIMOL? We notify you, reason included.
Follow IMMO MEDIMOLDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Dr. L. Vande Kerckhove comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
IMMO MEDIMOLBehind IMMO MEDIMOL are Ruud Koevoets, Massimo Romagnoli, Aydin Basoglu, Henricus Striekwold, Xavier De Meester and Laurent Vande Kerckhove. The shares are held by Dr. L. Vande Kerckhove (15%).
Directors
According to the 2025 annual accounts
Massimo Romagnoli
Director
Also active at: Polikliniek Medimol, Mol Cardio Vasculair, DR. M. ROMAGNOLI
Henricus Striekwold
Director
Also active at: IMMO STRIEKWOLD-SIERO, Polikliniek Medimol, Mol Cardio Vasculair
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Markt 43
2400 Mol
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0823.052.819
- VAT number
- BE 0823.052.819
- Registered office
- Markt 43, 2400 Mol
- Names & denominations
- IMMO MEDIMOL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 February 2010
- Peppol
- Not registered